DAX24.386 ±0,0%Est505.614 -0,3%MSCI World4.330 -0,5%Top 10 Crypto17,00 -2,3%Nas22.788 -0,7%Bitcoin104.767 -1,7%Euro1,1655 -0,5%Öl65,72 +0,3%Gold3.983 +0,6%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 DroneShield A2DMAA AMD (Advanced Micro Devices) 863186 Plug Power A1JA81 NVIDIA 918422 RENK RENK73 Tesla A1CX3T D-Wave Quantum A3DSV9 NEL ASA A0B733 HENSOLDT HAG000 Novo Nordisk A3EU6F Siemens Energy ENER6Y Bayer BAY001 Palantir A2QA4J BASF BASF11
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX letztlich stabil -- US-Börsen in Rot -- Norwegen stockt RENK-Anteil auf -- Tesla mit Billig-Auto -- Novo Nordisk, AMD, Trilogy Metals, DroneShield, Rheinmetall, HENSOLDT, AppLovin im Fokus
Top News
Dollar-Schwäche und Bitcoin-Stärke? Trumps Krypto-Wette mit globalen Folgen für Anleger Dollar-Schwäche und Bitcoin-Stärke? Trumps Krypto-Wette mit globalen Folgen für Anleger
MoffettNathanson über die Alphabet-Aktie: Ist die Google-Mutter bald größer als NVIDIA? MoffettNathanson über die Alphabet-Aktie: Ist die Google-Mutter bald größer als NVIDIA?
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

AstraZeneca Aktie

Kaufen
Verkaufen
64.825,00 ARS +25,00 ARS +0,04 %
BUE
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Smartphone
KGV46,86Div. Rendite1,80%
ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINARDEUT112489

AstraZeneca Aktien News

DatumMeistgelesen
Business TimesAstraZeneca signs US$1.92 billion licensing deal with HK-listed CSPC
MarketWatchAstraZeneca to pay up to $2 billion to license cardiovascular drug
PR NewswireSOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing
PR NewswireSOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing
PR NewswireSOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing
PR NewswireSOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing
PR NewswireVoydeya approved in Canada as add-on therapy to ravulizumab or eculizumab for adults with the rare disease PNH who have residual hemolytic anemia due to extravascular hemolysis
PR NewswireVoydeya approved in Canada as add-on therapy to ravulizumab or eculizumab for adults with the rare disease PNH who have residual hemolytic anemia due to extravascular hemolysis
PR NewswireI-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer
PR NewswireAbelZeta announces clinical data showing preliminary anti-tumor activity for C-CAR031, an armored autologous GPC3 CAR-T, in patients with advanced hepatocellular carcinoma, at ASCO Annual Meeting 2024
PR NewswireAbelZeta Announces Abstract for C-CAR031 Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
PR NewswireAlexion Canada Raises Awareness for Rare Diseases Through International colourUp4RARE Campaign
PR NewswireAlexion Canada Raises Awareness for Rare Diseases Through International colourUp4RARE Campaign
PR NewswireSOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain
PR NewswireSOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain
PR NewswireSOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain
PR NewswireSOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain
PR NewswireCompugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer
PR NewswireAllorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca
PR NewswireAllorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca
PR NewswireAllorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca
PR NewswireAllorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca
PR NewswireCompugen will be Eligible to Receive $10 Million Milestone Payment upon Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer
PR NewswireKoselugo now available in Malaysia for paediatric patients with symptomatic neurofibromatosis type 1 (NF1) plexiform neurofibromas
PR NewswirePresage Biosciences Announces New Pharma Partnership to Evaluate Novel Immuno-Oncology Drug Combinations with CIVO® Technology
PR NewswireHealth Canada approves Ultomiris for adults with neuromyelitis optica spectrum disorder (NMOSD)
PR NewswireHealth Canada approves Ultomiris for adults with neuromyelitis optica spectrum disorder (NMOSD)
PR NewswireAlexion, AstraZeneca Rare Disease, concludes Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA) for Ultomiris for the treatment of patients with paroxysmal nocturnal hemog...
PR NewswireAlexion, AstraZeneca Rare Disease, concludes Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA) for Ultomiris for the treatment of patients with paroxysmal nocturnal hemog...
PR NewswireSOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care
PR NewswireSOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care
PR NewswireSOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care
PR NewswireSOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care
PR NewswireFusion Pharmaceuticals Announces Presentation of Preclinical Data Supporting FPI-2068, a Novel Targeted Alpha Therapy for EGFR-cMET Expressing Cancers
PR NewswireFusion Pharmaceuticals Announces Presentation of Preclinical Data Supporting FPI-2068, a Novel Targeted Alpha Therapy for EGFR-cMET Expressing Cancers
PR NewswireASTRAZENECA AND INSTITUT KANSER NEGARA PARTNER TO INTRODUCE AI TECHNOLOGY FOR LUNG SCREENING
PR NewswireShanghai Cellular Biopharmaceutical Group presents first data from Phase I trial evaluating a novel CAR-T in advanced liver cancer at AACR Annual Meeting
PR NewswireShanghai Cellular Biopharmaceutical Group presents first data from Phase I trial evaluating a novel CAR-T in advanced liver cancer at AACR Annual Meeting
PR NewswireShanghai Cellular Biopharmaceutical Group presents first data from Phase I trial evaluating a novel CAR-T in advanced liver cancer at AACR Annual Meeting
PR NewswireShanghai Cellular Biopharmaceutical Group presents first data from Phase I trial evaluating a novel CAR-T in advanced liver cancer at AACR Annual Meeting

AstraZeneca News

AstraZeneca News: auf dieser Seite finden Sie alle AstraZeneca News und Nachrichten zur AstraZeneca Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch AstraZeneca News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um AstraZeneca News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.